VERONA PHARMA PLC - AMERICAN DEPOSITARY SHARES

Verona Pharma to Announce Top-line Data from Phase 3 ENHANCE-2 Trial of Nebulized Ensifentrine for COPD

08 8 2022 16:30:00 提供 Nasdaq GlobeNewswire

Verona Pharma to Report Second Quarter 2022 Financial Results and Provide Corporate Update

29 7 2022 02:00:00 提供 Nasdaq GlobeNewswire

Verona Pharma Completes Enrollment in Phase 3 ENHANCE-1 Trial Evaluating Ensifentrine for Maintenance Treatment of COPD

09 6 2022 02:00:00 提供 Nasdaq GlobeNewswire

Verona Pharma to Host KOL Event on June 16, 2022

06 6 2022 02:00:00 提供 Nasdaq GlobeNewswire

Verona Pharma to Present at Jefferies Healthcare Conference

25 5 2022 02:00:00 提供 Nasdaq GlobeNewswire

Verona Pharma to Present Successful TQT Analysis Demonstrating No Clinically Relevant Effect on Cardiac Conduction at the American Thoracic Society 2022

09 5 2022 02:00:00 提供 Nasdaq GlobeNewswire

Verona Pharma Announces May 2022 Investor Conference Participation

04 5 2022 02:00:00 提供 Nasdaq GlobeNewswire

Verona Pharma Reports First Quarter 2022 Financial Results and Provides Corporate Update

03 5 2022 02:00:00 提供 Nasdaq GlobeNewswire

Verona Pharma to Report First Quarter 2022 Financial Results and Provide Corporate Update

19 4 2022 02:00:00 提供 Nasdaq GlobeNewswire

James Brady Joins Verona Pharma as Non-Executive Director

14 3 2022 03:00:00 提供 Nasdaq GlobeNewswire

Verona Pharma Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

03 3 2022 02:00:00 提供 Nasdaq GlobeNewswire

Verona Pharma to Report Fourth Quarter and Full Year 2021 Financial Results and Provide Corporate Update

17 2 2022 02:00:00 提供 Nasdaq GlobeNewswire

Verona Pharma Completes Enrollment in Phase 3 ENHANCE-2 Trial Evaluating Ensifentrine for Maintenance Treatment of COPD

24 1 2022 02:00:00 提供 Nasdaq GlobeNewswire

Verona Pharma Completes Enrollment in ENHANCE-1 48-week Subset

05 1 2022 02:00:00 提供 Nasdaq GlobeNewswire

Verona Pharma to Present at H.C. Wainwright BioConnect Virtual Conference

04 1 2022 02:00:00 提供 Nasdaq GlobeNewswire

Verona Pharma Reports TQT Study Successfully Demonstrated No Clinically Relevant Effect on Cardiac Conduction

16 12 2021 02:00:00 提供 Nasdaq GlobeNewswire

Verona Pharma Reports Third Quarter 2021 Financial Results and Provides Corporate Update

09 11 2021 02:00:00 提供 Nasdaq GlobeNewswire

Verona Pharma to Report Third Quarter 2021 Financial Results and Provide Corporate Update

26 10 2021 02:00:00 提供 Nasdaq GlobeNewswire

Verona Pharma to Present Phase 2 Data with pMDI Ensifentrine in COPD at CHEST 2021

13 10 2021 02:00:00 提供 Nasdaq GlobeNewswire

Verona Pharma Presents Pharmacokinetic Data with Ensifentrine at the European Respiratory Society International Congress 2021

02 9 2021 02:00:00 提供 Nasdaq GlobeNewswire